BASF vs LyondellBasell Industries NV: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

BASF SE (BAS.XETRA)

Q3 202630 Jun – 25 Sep 2026

▲2▼1

BASF's mixed Q3: asset sale, buyback, AI bet, but Rhine and EU risks

Coatings sale completed BASF finished selling its coatings business to Carlyle for €7.7bn, boosting cash, profit, and earnings per share while keeping a 40% stake. This strengthens the balance sheet and supports shareholder returns.
Major completed deal that directly improved financials and cash flow.
AI investment and buyback BASF invested $1.1bn in AI for medical plastics and started a €1bn share buyback. These moves aim to drive future growth and return cash to shareholders, signaling confidence.
New strategic investments and capital returns that could lift investor sentiment.
Rhine water and EU emissions risks Record-low Rhine water levels threaten production and raw-material supplies, while an EU emissions overhaul could raise costs. These factors create operational and regulatory uncertainty.
Key external risks that could disrupt operations and increase expenses.
Evonik takeover talks BASF proposed a €12bn takeover of Evonik, which could create a European chemicals giant, but talks are early and shares fell nearly 2% on integration and funding concerns.
Potential transformative deal with uncertain outcome and negative initial market reaction.

August 202629 Jul – 25 Sep 2026

▲2▼1

BASF beats on profit, buys back stock, faces Rhine risk, eyes Evonik

Q2 profit surge and €1bn buyback BASF's Q2 net income jumped to €4.14bn, helped by a €3.5bn gain from selling its Coatings unit. It kept its upgraded 2026 profit forecast and will start a €1bn share buyback in August, part of a €4bn plan. Buybacks reduce shares outstanding, which can lift the stock price.
This is the period's biggest positive fundamental news and directly supports the share price.
Polyurethane price hikes lift chemical margins BASF and rivals like Wanhua and Huntsman raised MDI and TDI prices in late July and August. BASF is the world's second-largest MDI producer. Higher selling prices for these key chemicals can boost revenue and profit margins, pushing the stock up.
It shows a broad industry pricing upturn that directly benefits BASF's earnings.
Low Rhine water threatens production and supplies The Rhine fell to record-low levels, disrupting barge shipping. BASF's CEO said some product supplies can't be fully secured and the risk of production interruptions rises weekly. BASF gets about 40% of raw materials via the river, so continued drought could raise costs and cut output.
This is a real operational risk that could hurt earnings and weigh on the stock.
Takeover proposal for Evonik BASF proposed buying rival Evonik, which has a €12bn enterprise value. A deal would create a €74bn-revenue European chemicals giant better able to compete with Chinese and US rivals. But talks are early and may fail; BASF shares fell nearly 2% on the news, reflecting integration and funding concerns.
This is the period's major strategic move, with both potential long-term benefits and near-term uncertainty for BASF's stock.

Latest29 Jul – 25 Sep 2026

▲2▼1

BASF beats on profit, buys back stock, faces Rhine risk, eyes Evonik

Q2 profit surge and €1bn buyback BASF's Q2 net income jumped to €4.14bn, helped by a €3.5bn gain from selling its Coatings unit. It kept its upgraded 2026 profit forecast and will start a €1bn share buyback in August, part of a €4bn plan. Buybacks reduce shares outstanding, which can lift the stock price.
This is the period's biggest positive fundamental news and directly supports the share price.
Polyurethane price hikes lift chemical margins BASF and rivals like Wanhua and Huntsman raised MDI and TDI prices in late July and August. BASF is the world's second-largest MDI producer. Higher selling prices for these key chemicals can boost revenue and profit margins, pushing the stock up.
It shows a broad industry pricing upturn that directly benefits BASF's earnings.
Low Rhine water threatens production and supplies The Rhine fell to record-low levels, disrupting barge shipping. BASF's CEO said some product supplies can't be fully secured and the risk of production interruptions rises weekly. BASF gets about 40% of raw materials via the river, so continued drought could raise costs and cut output.
This is a real operational risk that could hurt earnings and weigh on the stock.
Takeover proposal for Evonik BASF proposed buying rival Evonik, which has a €12bn enterprise value. A deal would create a €74bn-revenue European chemicals giant better able to compete with Chinese and US rivals. But talks are early and may fail; BASF shares fell nearly 2% on the news, reflecting integration and funding concerns.
This is the period's major strategic move, with both potential long-term benefits and near-term uncertainty for BASF's stock.

July 202630 Jun – 17 Jul 2026

▲3▼1

BASF sells coatings, invests in AI, faces EU emissions overhaul

Coatings sale completed BASF finished selling its coatings unit to Carlyle for €7.7 billion, bringing in about €5.8 billion in cash and a one-time gain that lifts reported profit and earnings per share. It keeps a 40% stake in the new company, so it still shares in future upside.
This is the single biggest event of the period, directly boosting BASF's cash and reported earnings.
New bio-identical collagen launch BASF and Bota Biosciences launched a new lab-made collagen ingredient for personal care. It is a fresh product that could add sales in the higher-margin beauty ingredients market, showing BASF's push into specialty chemicals beyond basic plastics.
A concrete new product launch that supports future revenue growth in a profitable segment.
AI investment in medical plastics BASF is putting $1.1 billion into AI reactor technology for medical plastics, part of a broader $2.3 billion industry push. This could make production more efficient and open new high-value markets, though the payoff will take years.
Shows BASF investing in technology that may improve margins and competitiveness over time.
EU emissions trading overhaul The EU is revising its carbon permit system, which could raise costs for heavy polluters like BASF. BASF is lobbying for a slower pace, warning that strict rules risk pushing industry out of Europe. The final outcome is still uncertain, but tighter rules would weigh on profits.
A regulatory risk that could increase BASF's operating costs and affect its European competitiveness.

30 Jun – 17 Jul 2026

▲3▼1

BASF sells coatings, invests in AI, faces EU emissions overhaul

Coatings sale completed BASF finished selling its coatings unit to Carlyle for €7.7 billion, bringing in about €5.8 billion in cash and a one-time gain that lifts reported profit and earnings per share. It keeps a 40% stake in the new company, so it still shares in future upside.
This is the single biggest event of the period, directly boosting BASF's cash and reported earnings.
New bio-identical collagen launch BASF and Bota Biosciences launched a new lab-made collagen ingredient for personal care. It is a fresh product that could add sales in the higher-margin beauty ingredients market, showing BASF's push into specialty chemicals beyond basic plastics.
A concrete new product launch that supports future revenue growth in a profitable segment.
AI investment in medical plastics BASF is putting $1.1 billion into AI reactor technology for medical plastics, part of a broader $2.3 billion industry push. This could make production more efficient and open new high-value markets, though the payoff will take years.
Shows BASF investing in technology that may improve margins and competitiveness over time.
EU emissions trading overhaul The EU is revising its carbon permit system, which could raise costs for heavy polluters like BASF. BASF is lobbying for a slower pace, warning that strict rules risk pushing industry out of Europe. The final outcome is still uncertain, but tighter rules would weigh on profits.
A regulatory risk that could increase BASF's operating costs and affect its European competitiveness.

LyondellBasell Industries NV (LYB)

Q3 20268 Jul – 25 Aug 2026

▲3

LYB's profit rebound, dividend reset and Shell asset bid reshape the story

Recycled packaging deal adds a demand outlet LYB is supplying its CirculenRevive recycled polymers for new Marabou chocolate packaging with Mondelez, Amcor and Taghleef. It is a small but real new sales channel for recycled plastic, and it lines up with EU rules requiring more recycled content, which supports future demand for LYB's output.
New contract shows a concrete demand outlet for LYB's recycled polymers.
Q2 profit jumped on tight polyethylene supply LYB earned $558 million in Q2 2026, far above a year earlier, because supply problems in Middle Eastern polyethylene plants tightened the market and lifted prices. The catch: this strength came from someone else's disruption, so profits could fade if global petrochemical oversupply returns.
The earnings rebound is the core reason LYB's profit picture improved this period.
Dividend cut frees cash and draws an upgrade LYB halved its quarterly dividend to $0.69, ending 15 years of increases, but kept a pledge to return 70% of free cash flow. J.P. Morgan upgraded the stock to Overweight with an $80 target, citing roughly 12-14% free cash flow yield and falling debt. Less dividend paid means more cash to cut debt and fund projects.
The dividend reset and upgrade changed how investors judge LYB's cash generation and balance sheet.
Interest in Shell's US chemicals assets cuts both ways LYB is reported among bidders, with Exxon and others, for Shell's US chemical plants, a deal that could reach $8 billion. Buying them could expand LYB's scale and cut costs, but it is unconfirmed, early-stage and would add debt and integration risk during a weak petrochemical market.
A possible large acquisition is a major new swing factor for LYB's value and risk.

August 20268 Jul – 25 Aug 2026

▲3

LYB's profit rebound, dividend reset and Shell asset bid reshape the story

Recycled packaging deal adds a demand outlet LYB is supplying its CirculenRevive recycled polymers for new Marabou chocolate packaging with Mondelez, Amcor and Taghleef. It is a small but real new sales channel for recycled plastic, and it lines up with EU rules requiring more recycled content, which supports future demand for LYB's output.
New contract shows a concrete demand outlet for LYB's recycled polymers.
Q2 profit jumped on tight polyethylene supply LYB earned $558 million in Q2 2026, far above a year earlier, because supply problems in Middle Eastern polyethylene plants tightened the market and lifted prices. The catch: this strength came from someone else's disruption, so profits could fade if global petrochemical oversupply returns.
The earnings rebound is the core reason LYB's profit picture improved this period.
Dividend cut frees cash and draws an upgrade LYB halved its quarterly dividend to $0.69, ending 15 years of increases, but kept a pledge to return 70% of free cash flow. J.P. Morgan upgraded the stock to Overweight with an $80 target, citing roughly 12-14% free cash flow yield and falling debt. Less dividend paid means more cash to cut debt and fund projects.
The dividend reset and upgrade changed how investors judge LYB's cash generation and balance sheet.
Interest in Shell's US chemicals assets cuts both ways LYB is reported among bidders, with Exxon and others, for Shell's US chemical plants, a deal that could reach $8 billion. Buying them could expand LYB's scale and cut costs, but it is unconfirmed, early-stage and would add debt and integration risk during a weak petrochemical market.
A possible large acquisition is a major new swing factor for LYB's value and risk.

Latest8 Jul – 25 Aug 2026

▲3

LYB's profit rebound, dividend reset and Shell asset bid reshape the story

Recycled packaging deal adds a demand outlet LYB is supplying its CirculenRevive recycled polymers for new Marabou chocolate packaging with Mondelez, Amcor and Taghleef. It is a small but real new sales channel for recycled plastic, and it lines up with EU rules requiring more recycled content, which supports future demand for LYB's output.
New contract shows a concrete demand outlet for LYB's recycled polymers.
Q2 profit jumped on tight polyethylene supply LYB earned $558 million in Q2 2026, far above a year earlier, because supply problems in Middle Eastern polyethylene plants tightened the market and lifted prices. The catch: this strength came from someone else's disruption, so profits could fade if global petrochemical oversupply returns.
The earnings rebound is the core reason LYB's profit picture improved this period.
Dividend cut frees cash and draws an upgrade LYB halved its quarterly dividend to $0.69, ending 15 years of increases, but kept a pledge to return 70% of free cash flow. J.P. Morgan upgraded the stock to Overweight with an $80 target, citing roughly 12-14% free cash flow yield and falling debt. Less dividend paid means more cash to cut debt and fund projects.
The dividend reset and upgrade changed how investors judge LYB's cash generation and balance sheet.
Interest in Shell's US chemicals assets cuts both ways LYB is reported among bidders, with Exxon and others, for Shell's US chemical plants, a deal that could reach $8 billion. Buying them could expand LYB's scale and cut costs, but it is unconfirmed, early-stage and would add debt and integration risk during a weak petrochemical market.
A possible large acquisition is a major new swing factor for LYB's value and risk.